Able Wealth Management’s Cymabay Therapeutics CBAY Stock Holding History

Able Wealth Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-83	Closed	-$1.96K	–	608
2023 Q4	$1.96K	Buy	+83	New	+$1.48K	﹤0.01%	458

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Able Wealth Management's CBAY Position: Q1 2024 in Review

Able Wealth Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 83 shares — an estimated $1.96K sold.

Able Wealth Management first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $1.96K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Able Wealth Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Able Wealth Management sold 83 Cymabay Therapeutics shares in Q1 2024, an estimated $1.96K.
Able Wealth Management first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Able Wealth Management's Cymabay Therapeutics position peaked at $1.96K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Able Wealth Management's 13F filing for Q1 2024, filed 1 Nov 2024.